I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Dylla, Douglas E
82
results:
Search for persons
X
Format
Online (81)
Mediatypes
Articles (Online) (72)
OpenAccess-fulltext (9)
Sorted by: Relevance
Sorted by: Year
?
1
Assessment of Drug–Drug Interaction Risk Between Intravenou..:
Mukherjee, Dwaipayan
;
Collins, Michelle
;
Dylla, Douglas E.
...
Infectious Diseases and Therapy. 12 (2023) 8 - p. 2057-2070 , 2023
Link:
https://doi.org/10.1007/..
?
2
Shorter Duration Hepatitis C Virus Treatment is Associated ..:
Martinez, Anthony
;
Cheng, Wei-Han
;
Marx, Steven E.
...
Advances in Therapy. 40 (2023) 8 - p. 3465-3477 , 2023
Link:
https://doi.org/10.1007/..
?
3
Reported adverse events related to use of hepatitis C virus..:
Martinez, Anthony
;
Khan, Tipu
;
Dylla, Douglas E.
...
Harm Reduction Journal. 20 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
4
Safety analysis of glecaprevir/pibrentasvir in patients wit..:
Feld, Jordan J.
;
Forns, Xavier
;
Dylla, Douglas E.
...
Journal of Viral Hepatitis. 29 (2022) 12 - p. 1050-1061 , 2022
Link:
https://doi.org/10.1111/..
?
5
Healthcare resource utilization in Hepatitis C-infected pat..:
Valdez, Katia E.
;
Javanbakht, Marjan
;
Keith, Kori
...
Frontiers in Gastroenterology. 1 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
6
Epidemiology and Clinical Characteristics of Individuals wi..:
Reau, Nancy
;
Sulkowski, Mark S.
;
Thomas, Emmanuel
...
Advances in Therapy. 38 (2021) 12 - p. 5777-5790 , 2021
Link:
https://doi.org/10.1007/..
?
7
Positive predictive value of sustained virologic response 4..:
Gane, Edward
;
de Ledinghen, Victor
;
Dylla, Douglas E.
...
Journal of Viral Hepatitis. 28 (2021) 11 - p. 1635-1642 , 2021
Link:
https://doi.org/10.1111/..
?
8
Safety of Patients with Hepatitis C Virus Treated with Glec..:
Forns, Xavier
;
Feld, Jordan J.
;
Dylla, Douglas E.
...
Advances in Therapy. 38 (2021) 6 - p. 3409-3426 , 2021
Link:
https://doi.org/10.1007/..
?
9
Awareness and Epidemiology of Chronic Hepatitis C Virus Inf..:
Thomas, Emmanuel
;
Cheng, Wei-Han
;
Dylla, Douglas E.
...
Infectious Diseases and Therapy. 11 (2021) 1 - p. 451-462 , 2021
Link:
https://doi.org/10.1007/..
?
10
High Sustained Virologic Response Rates of Glecaprevir/Pibr..:
Zamor, Philippe J.
;
Brown, Ashley
;
Dylla, Douglas E.
...
American Journal of Gastroenterology. 116 (2021) 9 - p. 1896-1904 , 2021
Link:
https://doi.org/10.14309..
?
11
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is S..:
Zuckerman, Eli
;
Gutierrez, Julio A.
;
Dylla, Douglas E.
...
Clinical Gastroenterology and Hepatology. 18 (2020) 11 - p. 2544-2553.e6 , 2020
Link:
https://doi.org/10.1016/..
?
12
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatm..:
Flamm, Steven L.
;
Kort, Jens
;
Marx, Steven E.
...
Advances in Therapy. 37 (2020) 5 - p. 2267-2274 , 2020
Link:
https://doi.org/10.1007/..
?
13
Lentiviral Vector Gene Transfer to Porcine Airways:
Sinn, Patrick L
;
Cooney, Ashley L
;
Oakland, Mayumi
...
Molecular Therapy - Nucleic Acids. 1 (2012) - p. e56 , 2012
Link:
https://doi.org/10.1038/..
?
14
Altering α-dystroglycan receptor affinity of LCMV pseudotyp..:
Dylla, Douglas E
;
Xie, Litao
;
Michele, Daniel E
..
Genetic Vaccines and Therapy. 9 (2011) 1 - p. , 2011
Link:
https://doi.org/10.1186/..
?
15
689. Restriction Profiles of Primate TRIM5α on FIV:
Dylla, Douglas E.
;
Hickey, Melissa A.
;
Hatziioannou, Theodora
..
Molecular Therapy. 13 (2006) - p. S266-S267 , 2006
Link:
https://doi.org/10.1016/..
1-15